Study Findings from Thomas Jefferson University Hospital Provide New Insights into Sirolimus Therapy (A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report)

Press/Media

PeriodMay 1 2023

Media coverage

1

Media coverage